Quest Diagnostics
DGX
#1160
Rank
$15.35 B
Marketcap
$138.20
Share price
0.66%
Change (1 day)
0.12%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Number of shares outstanding for Quest Diagnostics (DGX)

Number of shares outstanding as of June 2024 : 111,000,000

According to Quest Diagnostics 's latest financial reports and stock price the company's current number of shares outstanding is 111,000,000. At the end of 2024 the company had 111,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Quest Diagnostics from 2005 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.11 B-0.89%
20230.11 B-0.88%
20220.11 B-7.38%
20210.12 B-9.63%
20200.13 B0.75%
20190.13 B-1.47%
20180.13 B0%
20170.13 B-1.45%
20160.13 B-3.5%
20150.14 B-1.38%
20140.14 B-0.68%
20130.14 B-8%
20120.15 B0.57%
20110.15 B-8.89%
20100.17 B-6.43%
20090.18 B-5.06%
20080.19 B0.82%
20070.19 B-1.92%
20060.19 B-2.72%
20050.20 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
84,100,000-24.23%๐Ÿ‡บ๐Ÿ‡ธ USA
62,908,800-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
5,806,000-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
126,111,000 13.61%๐Ÿ‡บ๐Ÿ‡ธ USA
221,847,000 99.86%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
50,490,000-54.51%๐Ÿ‡บ๐Ÿ‡ธ USA